SuperGen to Present at the Fifth Annual Lazard Healthcare Conference on November 18, 2008
November 13 2008 - 8:00AM
PR Newswire (US)
DUBLIN, Calif., Nov. 13 /PRNewswire-FirstCall/ -- SuperGen, Inc.
(NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery
and development of novel cancer therapies, today announced that
James S. Manuso, Ph.D., President and Chief Executive Officer is
scheduled to present at the Fifth Annual Lazard Healthcare
Conference on Tuesday, November 18, 2008 at the St. Regis in New
York, New York. SuperGen's presentation at the Lazard Healthcare
Conference is scheduled to begin at 4:40 p.m. EDT (1:40 p.m. PDT).
A live webcast of the presentation will be available on the
investor relations section of the Company's Web site at
http://www.supergen.com/. The webcast will be archived for 90 days.
About SuperGen Based in Dublin, Calif., SuperGen, Inc. is a
pharmaceutical company dedicated to the discovery and development
of novel cancer therapies. SuperGen is developing a number of
therapeutic anticancer products focused on kinase and cell
signaling inhibitors and DNA methyltransferase inhibitors. For more
information about SuperGen, please visit http://www.supergen.com/.
Contacts: SuperGen, Inc. Dorland Global Public Relations Timothy L.
Enns Michael Beckerich (Media) SVP, Corporate Communications Tel:
(212) 677-7632 & Business Development Tel: (925) 560-2810
Email: DATASOURCE: SuperGen, Inc. CONTACT: Timothy L. Enns, SVP,
Corporate Communications & Business Development of SuperGen,
Inc., +1-925-560-2810, ; or Media, Michael Beckerich of Dorland
Global Public Relations, +1-212-677-7632, , for SuperGen, Inc. Web
site: http://www.supergen.com/
Copyright
Supergen, Inc. (MM) (NASDAQ:SUPG)
Historical Stock Chart
From Oct 2024 to Nov 2024
Supergen, Inc. (MM) (NASDAQ:SUPG)
Historical Stock Chart
From Nov 2023 to Nov 2024